Krishna Komanduri named division chief of hematology-oncology at UCSF Health

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.

UCSF Prostate Cancer Program receives $7M SPORE grant

The UCSF Prostate Cancer Program received the NCI’s Specialized Programs of Research Excellence, or SPORE, grant for prostate cancer.

September 06, 2024

Vol.50 No.33

In Brief

UCSF receives $5M donation to develop AI-monitoring platform for clinical care

The UCSF Division of Clinical Informatics and Digital Transformation and UCSF Health have received a $5 million gift from Ken and Kathy Hao to develop a cutting-edge, real-time, continuous, and automated artificial intelligence monitoring platform for clinical care.

May 31, 2024

Vol.50 No.22

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

At a time when distinguished careers can falter because of a careless Facebook post, the oncologist-iconoclast Vinay Prasad is showing no sign of moderating the shaming and haranguing that make him a social media phenom.

December 01, 2023

Vol.49 No.44

By Paul Goldberg

Conversation with The Cancer Letter

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

Vinay Prasad, a social media phenom and professor of epidemiology and biostatistics at the University of California, San Francisco, recently stunned his colleagues by stating that doctors at Vanderbilt University acted in a “despicable” manner when they offered a double lung transplant to a lung cancer patient. “The doctors at Vanderbilt are despicable in my...

UCSF researchers uncover pathway for molecular cancer drug therapies

In a study published in Science, UCSF researchers Kevin Lou, Luke Gilbert, and Kevan Shokat demonstrated the discovery of a cellular uptake pathway important for large and complex molecules, which bind in unconventional ways to their targets and are efficiently taken up by target cells.

December 09, 2022

Vol.48 No.44

Krishna Komanduri named division chief of hematology-oncology at UCSF Health

YOU MAY BE INTERESTED IN

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

UCSF Prostate Cancer Program receives $7M SPORE grant

UCSF receives $5M donation to develop AI-monitoring platform for clinical care

Vinay Prasad describes his Vanderbilt colleagues as “despicable,” raising new questions about physicians’ conduct on social media

Prasad could not have had patient data when he called Vanderbilt colleagues “despicable”

UCSF researchers uncover pathway for molecular cancer drug therapies

Renew today!

Subscriber content

Never miss an issue!

Login